|Day's Range||0.35 - 0.38|
|52 Week Range||0.30 - 0.94|
|PE Ratio (TTM)||-27.64|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The Shijiazhuang City, China-based company said it had net income of less than 1 cent on a per-share basis. The specialty pharmaceutical company posted revenue of $5.7 million in the period. The company's ...
Categories: Yahoo Finance Get free summary analysis Aoxing Pharmaceutical Co., Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Aoxing Pharmaceutical Co., Inc. – Pfizer Inc., Impax Laboratories, Inc., Johnson & Johnson, Mylan N.V., Amicus Therapeutics, Inc. and Array BioPharma Inc. (PFE-US, IPXL-US, JNJ-US, MYL-US, FOLD-US ... Read more (Read more...)
Aoxing Pharmaceutical Company hit another 52-week low on Oct. 17. Can the company save itself from potential bankruptcy?